About tice bcg
Live attenuated intravesical tuberculosis vaccine
Used for
- Treats non-muscle-invasive bladder cancer, including carcinoma in situ
- Helps prevent recurrence after bladder tumor removal
Usual adult dose
Usually instilled into the bladder weekly for six weeks; maintenance courses may follow, per specialist protocol.
Common side effects
- Bladder irritation, frequent or painful urination
- Blood in urine
- Fever, chills, or flu-like symptoms
- Rare, serious widespread BCG infection
Important warnings
- For bladder instillation only; never inject into a vein or muscle.
- Treatment is delayed during urinary infection, visible blood in urine, or after traumatic catheterization.
- Seek urgent care for persistent fever or signs of infection.
- Avoid in severe immune suppression; live BCG can cause serious infection.
Pregnancy
Not recommended during pregnancy; potential fetal harm is uncertain. Avoid pregnancy during treatment.
Breastfeeding
Breastfeeding safety is unknown; treatment is generally avoided while breastfeeding.
Interactions
- Immune-suppressing medicines may reduce effectiveness and increase infection risk.
- Antibiotics active against tuberculosis bacteria may reduce treatment effectiveness.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.